If you’re close to 50 years old (or older), you need to read this immediately… Because your retirement is in jeopardy. This isn’t about not being able to retire “on time.” It’s about not being able to retire at all.
As Wayne and I have been explaining recently, there’s one trend you absolutely need to be investing in right now: Biotech. Most investors avoid this lucrative sector because, frankly, it can seem overwhelming.
Last Sunday morning, I took my 2-year-old son to a zoo. There were zebras, camels, and a kid-sized train that took him on a “safari.” Not bad, considering we were just an hour away from New York City.
Last week, I told you about the three big challenges of investing in small-cap stocks. But as I explained, there’s one tiny corner of the market where you could overcome those challenges.
For the last few weeks, Wayne and I have been explaining why small-cap stocks are one of the best ways to make big gains, fast. But not just any kind of small-caps… instead, small-caps from one specific sector.
In this column last Wednesday, I introduced you to the “perfect” investment: startups. The following day, however, Wayne revealed some of the pitfalls of these deals.
Investors in private startups pocketed a fortune last quarter… According to a report released last week, they took home $103.9 billion. That’s a record high — and as you’re about to learn, those profits are expected to keep flowing.